Rothschild & Co Redburn Downgrades Insulet Corporation (PODD), Cites "Eroding" Product Moats and Distribution
Insulet Corporation (NASDAQ:PODD) is one of the best medical device stocks to invest in right now.
Insulet Corp (PODD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 139,407 | $29,253,165 | +24% | 0.84% |
| 2. | Ayrshire Capital Management John Nevin Jr. | 4,932 | $1,035,024 | -3% | 0.54% |
| 3. | Bayforest Capital Theodoros Tsagaris | 308 | $64,631 | -61% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $246.23 | 2,030 | $499,846.90 | 17,483 | 2026-02-25 | Filing | |
| $239.35 | 4,300 | $1,029,205.00 | 13,916 | 2026-02-20 | Filing | |
| $311.73 | 962 | $299,884.26 | 4,591 | 2025-12-05 | Filing | |
| $206.00 | 100 | $20,600.00 | 13,314 | 2024-08-29 | Filing | |
| $168.92 | 1 | $168.92 | 4,032 | 2023-09-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $293.09 | 1,851 | $542,509.59 | 2,158 | 2025-12-15 | Filing | |
| $347.49 | 687 | $238,725.63 | 3,456 | 2025-09-08 | Filing | |
| $348.81 | 797 | $278,001.57 | 3,890 | 2025-09-08 | Filing | |
| $332.23 | 4,263 | $1,416,296.49 | 16,736 | 2025-08-21 | Filing | |
| $320.00 | 1,343 | $429,760.00 | 4,143 | 2025-08-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 394,300 | $82,724,140 | 0.4% | |
| 2. | 298,791 | $62,698,303 | 0.02% | |
| 3. | 257,719 | $54,079,755 | 0.08% | |
| 4. | 244,757 | $51,359,809 | 0.08% | |
| 5. | 202,246 | $42,439,301 | 1.14% |
News See All
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity markets.
12 Best Growth Stocks to Buy and Hold in 2026
On April 24, the S&P 500 and Nasdaq closed at all-time highs; however, the bigger story is what's driving them there and what's coming next.
Jim Cramer Highlighted 21 Stocks, Including Dow and Home Depot
In this article, we will look at Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks.
Is Insulet Corporation (PODD) One of the Most Oversold Healthcare Stocks to Invest In?
Insulet Corporation (NASDAQ:PODD) is one of the most oversold healthcare stocks to invest in. Insulet Corporation (NASDAQ:PODD) received a rating update from Truist on April 15.
8 Most Oversold Healthcare Stocks to Invest In
Calling it a textbook classic move, he stated that we had a geopolitical shock and markets sold off hard before snapping right back up, making it the classic V shape.
Citi Flags Competitive Pressure as Key Risk for Insulet Corporation (PODD)
TheFly reported on April 7 that Citigroup lowered PODD from Buy to Neutral and reduced its price target to $230 from $338 ahead of the company’s first-quarter results.
10 Best Beaten Down Stocks to Invest in According to Analysts
When markets start to mistake short-term losses for long-term declines, oversold equities frequently get fresh attention. This is the point at which insider purchasing becomes especially significant.
12 Oversold Blue Chip Stocks to Buy According to Analysts
Oversold blue chip stocks are drawing a closer look, but not just because they have fallen.
7 Oversold Stocks to Buy with Double-Digit ROE Growth
In this article, we will look at oversold names that offer double-digit ROE growth for investors across sectors.
Hedge Fund Resource Center